Α/β/Œ≥PAK Antibody

• Description:

  α/β/γPAK Antibody_x000D_ Catalog number: B2015962_x000D_ Lot number: Batch Dependent_x000D_ Expiration Date: Batch dependent_x000D_ Amount: 50 ug_x000D_ Molecular Weight or Concentration: 67/68/62 kD_x000D_ Supplied as: Solution_x000D_ Applications: a molecular tool for various biochemical applications_x000D_ Storage: 2-8° C_x000D_ Keywords: α/β/γPAK Antibody_x000D_ Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ References:_x000D_ 1: Neudauer CL, Joberty G, Tatsis N, Macara IG. Distinct cellular effects and interactions of the Rho-family GTPase TC10 Curr Biol. 1998 Oct 22;8(21):1151-60._x000D_ 2: Swain SM, Shastry M, Hamilton E. Targeting HER2-positive breast cancer: advances and future directions Nat Rev Drug Discov. 2023 Feb;22(2):101-126._x000D_ 3: Merle G, Friedlaender A, Desai A, Addeo A. Antibody Drug Conjugates in Lung Cancer Cancer J. 2022 Nov-Dec 01;28(6):429-435._x000D_ 4: Kong C, Pu J, Zhao Q, Weng W, Ma L, Qian Y, Hu W, Meng X, Meng T. MTX-13, a Novel PTK7-Directed Antibody-Drug Conjugate with Widened Therapeutic Index Shows Sustained Tumor Regressions for a Broader Spectrum of PTK7-Positive Tumors Mol Cancer Ther. 2023 Oct 2;22(10):1128-1143._x000D_ 5: Abelman RO, Medford A, Spring L, Bardia A. Antibody-Drug Conjugates in Breast Cancer: Spotlight on HER2 Cancer J. 2022 Nov-Dec 01;28(6):423-428._x000D_ 6: Yamori T, Kong D. [Kinase inhibitors] Nihon Rinsho. 2010 Jun;68(6):1059-66._x000D_ 7: Vakrakou AG, Karachaliou E, Chroni E, Zouvelou V, Tzanetakos D, Salakou S, Papadopoulou M, Tzartos S, Voumvourakis K, Kilidireas C, Giannopoulos S, Tsivgoulis G, Tzartos J. Immunotherapies in MuSK-positive Myasthenia Gravis; an IgG4 antibody-mediated disease Front Immunol. 2023 Jul 26;14:1212757._x000D_ 8: Misselwitz B, Juillerat P, Sulz MC, Siegmund B, Brand S; Swiss IBDnet, an official working group of the Swiss Society of Gastroenterology. Emerging Treatment Options in Inflammatory Bowel Disease: Janus Kinases, Stem Cells, and More Digestion. 2020;101 Suppl 1:69-82._x000D_ 9: MacGlashan D Jr. Reply J Allergy Clin Immunol. 2019 Aug;144(2):623-624._x000D_ 10: Hughes A, Clarson J, Gargett T, Yu W, Brown MP, Lopez AF, Hughes TP, Yong AS. Comment on "KB004, a first in class monoclonal antibody targeting the receptor tyrosine kinase EphA3, in patients with advanced hematologic malignancies: Results from a phase 1 study" Leuk Res. 2017 Apr;55:55-57. _x000D_ _x000D_ Products Related to α/β/γPAK Antibody can be found at Antibodies

• Short Description:

  Catalog Number: B2015962 (50 ug)

• Weight:

  0.15

• Length:

  2

• Width:

  0.5

• Height:

  0.5

• Height :

  0.5

• CAS Number:

  9007-83-4